VERA Earnings Date: Nov 5, 2026 (Estimated) — Vera Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is VERA's next earnings date?
Vera Therapeutics, Inc. (VERA) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.61 on revenue of $3.9M.
How did VERA do in its last earnings report?
In its most recent report on Aug 10, 2026 (Q2 2026), Vera Therapeutics, Inc. posted EPS of -$1.52 versus the -$1.58 estimate, a beat of 4.4%. Revenue was $0 against a $1.3M estimate. The stock's 1-day post-earnings move was -4.1%.
How much does VERA stock move after earnings?
VERA beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.3% (up or down) in the day after earnings.
About Vera Therapeutics, Inc.
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is atacicept, a fusion protein that patients self-administer as a subcutaneous injection. This drug is currently undergoing Phase IIb clinical trials to treat immunoglobulin A nephropathy. The company is also advancing MAU868, a monoclonal antibody in Phase 2 clinical development, designed to combat BK viremia infections. Founded in 2016 and based in Brisbane, California, the organization operated as Trucode Gene Repair, Inc. until it rebranded to Vera Therapeutics, Inc. in April 2020.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | -1.58 | -1.52 | +4.40% | $0 | ✅ Beat | -4.08% | +0.16% | +6.97% |
| 2026-05-07 | Q1 2026 | -1.35 | -1.69 | -25.19% | $0 | ❌ Miss | -1.95% | +6.98% | -11.76% |
| 2026-02-26 | Q4 2025 | -1.30 | -1.39 | -6.92% | $0 | ❌ Miss | +1.61% | -4.87% | -3.41% |
| 2025-11-05 | Q3 2025 | -1.16 | -1.26 | -8.62% | $0 | ❌ Miss | -1.03% | +22.01% | +74.99% |
| 2025-08-05 | Q2 2025 | -0.70 | -1.20 | -71.43% | $0 | ❌ Miss | +0.93% | -1.37% | +12.27% |
| 2025-02-26 | Q4 2024 | -0.73 | -0.72 | +1.37% | $0 | ✅ Beat | +2.47% | +5.54% | -4.39% |
| 2024-11-07 | Q3 2024 | -0.64 | -0.85 | -32.81% | $0 | ❌ Miss | +2.29% | +3.11% | +1.08% |
| 2024-03-20 | Q4 2023 | -0.51 | -0.58 | -13.73% | $0 | ❌ Miss | +4.40% | -4.24% | -9.07% |
Showing last 8 quarters.